Stem Cell Transplant for Neuroblastoma: Pediatric Cancer Treatment Guide

A diagnosis of neuroblastoma can be overwhelming for any family. As one of the most common solid tumors in children, neuroblastoma accounts for approximately 7-10% of all pediatric cancers and is responsible for nearly 15% of childhood cancer-related deaths. While some forms of neuroblastoma can regress spontaneously or respond well to standard treatments, high-risk neuroblastoma remains one of the most challenging childhood cancers to treat.

Over the past two decades, significant advances in pediatric oncology have transformed treatment outcomes for children with high-risk neuroblastoma. Among these advances, autologous stem cell transplantation (ASCT) has emerged as a cornerstone of therapy. This treatment allows oncologists to administer intensive chemotherapy capable of destroying residual cancer cells while restoring the body's ability to produce healthy blood cells afterwards.

Today, stem cell transplantation is routinely incorporated into multimodal treatment plans that also include chemotherapy, surgery, radiation therapy, immunotherapy, and maintenance treatments. Although the procedure can be physically demanding, it has contributed significantly to improving long-term survival rates for children diagnosed with high-risk disease.

This guide explores everything parents and caregivers need to know about stem cell transplantation for neuroblastoma, including its role in treatment, eligibility criteria, procedure, recovery process, benefits, risks, and future innovations.

Understanding Neuroblastoma

Neuroblastoma is a cancer that develops from immature nerve cells called neuroblasts. These cells are part of the sympathetic nervous system, which controls involuntary body functions such as heart rate, blood pressure, and digestion. The disease most commonly develops in the adrenal glands located above the kidneys, but it can also arise in the chest, abdomen, neck, or pelvis.

Neuroblastoma primarily affects infants and young children, with most cases diagnosed before the age of five.

Common Symptoms of Neuroblastoma

Symptoms vary depending on the location and spread of the tumor but may include:

• Abdominal swelling or pain
• Persistent fatigue
• Unexplained weight loss
• Fever
• Bone pain
• Difficulty walking
• Bruising around the eyes
• High blood pressure
• Breathing difficulties
• Loss of appetite

Because symptoms often resemble those of common childhood illnesses, diagnosis may sometimes be delayed until the disease has progressed.

Risk Classification

Neuroblastoma is classified into different risk groups based on:

• Age at diagnosis
• Disease stage
• Tumor histology
• MYCN gene status
• Chromosomal abnormalities
• Response to initial therapy

Children categorised as high-risk are the most likely candidates for stem cell transplantation.

Need Expert Advice for Your Child's Neuroblastoma Treatment?

Connect with leading pediatric oncologists to understand treatment options.

Consult Specialists

Talk to Expert

What Is a Stem Cell Transplant?

A stem cell transplant is a medical procedure used to restore healthy blood-forming stem cells after intensive chemotherapy has damaged or destroyed the bone marrow.

Stem cells are immature cells capable of developing into:

• Red blood cells
• White blood cells
• Platelets

The transplant itself does not directly destroy neuroblastoma cells. Instead, it enables doctors to administer very high doses of chemotherapy that would otherwise permanently damage the bone marrow.

Once chemotherapy is completed, previously collected stem cells are returned to the patient's bloodstream, where they migrate to the bone marrow and begin producing healthy blood cells again.

For neuroblastoma, the most commonly used approach is an autologous stem cell transplant, meaning the child's own stem cells are collected and later reinfused.

Why is a Stem Cell Transplant Used for Neuroblastoma?

Even after chemotherapy and surgery, microscopic cancer cells may remain hidden in the body. These cells can eventually cause the disease to return.

High-dose chemotherapy is more effective at eliminating these residual cancer cells than standard chemotherapy. However, such intensive treatment severely damages the bone marrow.

Stem cell transplantation serves as a rescue mechanism, allowing doctors to safely deliver higher chemotherapy doses than would otherwise be possible.

Primary Goals of Stem Cell Transplantation

Numerous clinical studies have demonstrated that stem cell transplantation improves event-free survival and overall outcomes in children with high-risk neuroblastoma compared with conventional chemotherapy alone.

Who Needs a Stem Cell Transplant?

Stem cell transplantation is generally recommended for children diagnosed with high-risk neuroblastoma.

A child may be considered high-risk if:

• The disease has spread to distant organs.
• MYCN gene amplification is present.
• The tumor demonstrates aggressive biological features.
• The patient is older than 18 months at diagnosis with advanced disease.
• There is an incomplete response after initial treatment.

Not every child with neuroblastoma requires a stem cell transplant. Children with low-risk and many intermediate-risk tumors often achieve excellent outcomes with surgery and chemotherapy alone.

The Neuroblastoma Treatment Journey

Stem cell transplantation is not a standalone therapy. Instead, it is one component of a carefully planned treatment strategy.

Table 1: Standard Treatment Journey for High-Risk Neuroblastoma

Step-by-Step Stem Cell Transplant Process

Step 1: Induction Chemotherapy

Treatment begins with several cycles of intensive chemotherapy.

The objectives are to:

• Shrink the primary tumor
• Eliminate metastatic disease
• Improve surgical outcomes
• Prepare for transplantation

This phase usually lasts four to six months.

Step 2: Surgery

After chemotherapy, surgeons attempt to remove as much of the tumor as safely possible.

Complete removal may not always be feasible because tumors can surround critical organs and blood vessels.

Step 3: Stem Cell Collection

Before high-dose chemotherapy begins, doctors collect healthy stem cells from the child's bloodstream.

Growth factor medications are administered to stimulate stem cell production and encourage their movement from the bone marrow into the blood.

The collection procedure, known as apheresis, involves:

• Drawing blood from the patient
• Separating stem cells using a specialised machine
• Returning the remaining blood components

The collected stem cells are frozen and stored until transplantation.

Step 4: High-Dose Chemotherapy

• This phase is often referred to as myeloablative therapy.
• Very high doses of chemotherapy drugs are administered to destroy any remaining cancer cells.
• While effective against neuroblastoma, these drugs also eliminate healthy bone marrow cells.
• As a result, stem cell rescue becomes essential.

Step 5: Stem Cell Infusion

• Once chemotherapy is completed, the frozen stem cells are thawed and infused into the bloodstream through an intravenous catheter.
• The procedure is similar to a blood transfusion and is generally painless.
• The stem cells naturally migrate to the bone marrow, where they begin rebuilding healthy blood production.

Step 6: Engraftment

Engraftment occurs when transplanted stem cells start producing new blood cells.

During this period, children are closely monitored because they are highly vulnerable to:

• Infections
• Bleeding complications
• Severe anemia

Most patients remain hospitalised until blood counts recover adequately.

Types of Stem Cell Transplants Used in Neuroblastoma

Although several transplant approaches exist in oncology, neuroblastoma treatment primarily relies on autologous transplantation.

Table 2: Single vs Tandem Autologous Stem Cell Transplant

Tandem transplantation involves two separate autologous transplants performed several weeks or months apart. Some studies suggest this approach may further improve outcomes in selected high-risk patients.

Benefits of Stem Cell Transplantation

Stem cell transplantation has become a standard component of high-risk neuroblastoma treatment because of its ability to improve long-term outcomes.

Table 3: Benefits and Risks of Stem Cell Transplantation

Studies consistently show improved survival when stem cell transplantation is included in comprehensive treatment.

Risks and Side Effects

Because transplantation involves intensive chemotherapy, side effects are common.

Short-Term Side Effects

• Fatigue
• Fever
• Nausea and vomiting
• Mouth ulcers
• Loss of appetite
• Diarrhea
• Hair loss
• Increased infection risk
• Bleeding tendencies

Serious Complications

• Liver injury
• Kidney dysfunction
• Lung complications
• Cardiac toxicity
• Severe bloodstream infections

Fortunately, advances in supportive care have significantly reduced transplant-related mortality over the past two decades.

Recovery After Stem Cell Transplant

Recovery occurs gradually as stem cells rebuild healthy bone marrow.

Table 4: Recovery Timeline After Stem Cell Transplant

Every child recovers differently, and close medical monitoring remains essential throughout the recovery process.

Long-Term Outcomes and Survival

Survival outcomes for high-risk neuroblastoma have improved dramatically over the past several decades.

Table 5: Evolution of High-Risk Neuroblastoma Treatment

Current multimodal treatment approaches have increased long-term survival rates for many children with high-risk neuroblastoma to approximately 50–60%, a substantial improvement compared with historical outcomes.

Compare Top Hospitals

Explore internationally recognized pediatric cancer hospitals

Explore Hospitals

Chat with Our Healthcare Assistant

Trusted by 100000+ patients and leading medical experts.

Life After Stem Cell Transplant

Following treatment, survivors require ongoing medical follow-up.

Table 6: Long-Term Follow-Up Monitoring

Many children eventually return to normal activities, including school, sports, and social interactions.

Emerging Advances in Neuroblastoma Treatment

Researchers continue to develop innovative therapies to improve outcomes while reducing treatment toxicity.

Anti-GD2 Immunotherapy

Anti-GD2 antibodies have become a standard component of maintenance therapy following transplantation and have significantly improved survival outcomes.

CAR T-Cell Therapy

Scientists are investigating genetically modified immune cells capable of recognising and attacking neuroblastoma cells.

Precision Medicine

Genomic profiling is helping clinicians identify targeted therapies based on a tumor's unique molecular characteristics.

Improved Supportive Care

Advances in infection prevention, nutritional support, and critical care medicine continue to enhance transplant safety and recovery.

Conclusion

Stem cell transplantation has revolutionised the treatment of high-risk neuroblastoma and remains one of the most important advances in pediatric oncology. Enabling the safe administration of high-dose chemotherapy helps eliminate residual cancer cells and significantly improves survival outcomes.

Although the transplant journey can be physically and emotionally demanding, ongoing advances in immunotherapy, precision medicine, supportive care, and cellular therapies continue to provide new hope for children and families affected by this aggressive childhood cancer. Today, more children than ever before are achieving long-term remission and moving forward to healthy, productive lives.

Frequently Asked Questions